Lycia Therapeutics

company

About

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$70M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$120M
Lycia Therapeutics has raised a total of $120M in funding over 2 rounds. Their latest funding was raised on Sep 9, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 9, 2021 Series B $70M 1 — — Detail
Jun 9, 2020 Series A $50M 1 Versant Ventures — Detail

Investments

Number of Investments
Number of Lead Investments
34
0
Lycia Therapeutics has made 34 investments. Their most recent investment was on Jul 28, 2021, when Yield Guild Games raised $12.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 28, 2021 Yield Guild Games
Initial Coin Offering $12.50M Blockchain —
May 5, 2021 BitPay
Secondary Market — Bitcoin —
Jan 30, 2021 Aave
Secondary Market — Blockchain —
Jul 1, 2020 Terra
Secondary Market — Blockchain —
Aug 30, 2018 Circle
Secondary Market — Banking —

Investors

Number of Lead Investors
Number of Investors
1
1
Lycia Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series B